Joshiawa Paulk
Novartis (United States)(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Epigenetics and DNA Methylation, Multiple Myeloma Research and Treatments, RNA modifications and cancer
Most-Cited Works
- → Phthalimide conjugation as a strategy for in vivo target protein degradation(2015)1,681 cited
- → The dTAG system for immediate and target-specific protein degradation(2018)1,126 cited
- → MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells(2016)621 cited
- → BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment(2017)473 cited
- → A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader(2017)433 cited
- → Transcription control by the ENL YEATS domain in acute leukaemia(2017)318 cited
- → Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands(2017)284 cited
- → Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex(2019)249 cited
- → Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands(2018)223 cited
- → An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation(2016)206 cited